Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12342)
All Articles published online
|
Publishing Process of This Article
|
Aug 28, 2014 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rossi ML, Rehman AA, Gondi CS. Therapeutic options for the management of pancreatic cancer. World J Gastroenterol 2014; 20(32): 11142-11159 [PMID: 25170201 DOI: 10.3748/wjg.v20.i32.11142] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i32/11142.htm |
| Number | Citing Articles |
| 1 |
Jing Zhang, Xiongfei Xu, Min Shi, Ying Chen, Danghui Yu, Chenyan Zhao, Yan Gu, Biao Yang, Shiwei Guo, Guiling Ding, Gang Jin, Chin-Lee Wu, Minghua Zhu. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. OncoImmunology 2017; 6(2): e1258504 doi: 10.1080/2162402X.2016.1258504
|
| 2 |
Sanga Mitra, Sayak Ganguli, Jayprokas Chakrabarti. Cancer and Noncoding RNAs. 2018; : 1 doi: 10.1016/B978-0-12-811022-5.00001-2
|
| 3 |
Zhengliang Zhang, Xiangming Che, Ni Yang, Zhenghai Bai, Yuan Wu, Li Zhao, Honghong Pei. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. Biomedicine & Pharmacotherapy 2017; 96: 1341 doi: 10.1016/j.biopha.2017.11.074
|
| 4 |
Zhenyu Wang, Wenhao Shen, Xugang Li, Yang Feng, Kun Qian, Gaoren Wang, Yiying Gao, Xiaohui Xu, Shuyu Zhang, Ling Yue, Jianping Cao. <p>The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells</p>. Drug Design, Development and Therapy 2020; : 3099 doi: 10.2147/DDDT.S242557
|
| 5 |
Balbina García-Reyes, Anna-Laura Kretz, Jan-Philipp Ruff, Silvia Von Karstedt, Andreas Hillenbrand, Uwe Knippschild, Doris Henne-Bruns, Johannes Lemke. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2018; 19(10): 3219 doi: 10.3390/ijms19103219
|
| 6 |
Yanping Zhong, Jinsong Liu, Xiaoran Li, Shannon N. Westin, Anais Malpica, Barrett C. Lawson, Sanghoon Lee, Bryan M. Fellman, Robert L. Coleman, Anil K. Sood, Nicole D. Fleming. A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma after Neoadjuvant Chemotherapy. Cancers 2021; 13(4): 704 doi: 10.3390/cancers13040704
|
| 7 |
Mingkai Chen, Junfei Tan, Zihan Jin, Tingting Jiang, Jiabiao Wu, Xiaolong Yu. Research progress on Sirtuins (SIRTs) family modulators. Biomedicine & Pharmacotherapy 2024; 174: 116481 doi: 10.1016/j.biopha.2024.116481
|
| 8 |
Diana Behrens, Jana Rolff, Jens Hoffmann. New Approaches to Drug Discovery. Handbook of Experimental Pharmacology 2015; 232: 203 doi: 10.1007/164_2015_29
|
| 9 |
Juan Gonzalez-Valdivieso, Andres Garcia-Sampedro, Andrew R. Hall, Alessandra Girotti, Francisco Javier Arias, Stephen P. Pereira, Pilar Acedo. Smart Nanoparticles as Advanced Anti-Akt Kinase Delivery Systems for Pancreatic Cancer Therapy. ACS Applied Materials & Interfaces 2021; 13(47): 55790 doi: 10.1021/acsami.1c14592
|
| 10 |
Li Wang, Jun Luo, Yuchen Li, Yanrong Lu, Yi Zhang, Bole Tian, Ziyi Zhao, Qiong-ying Hu. RETRACTED: Mitochondrial-Associated Protein LRPPRC is Related With Poor Prognosis Potentially and Exerts as an Oncogene Via Maintaining Mitochondrial Function in Pancreatic Cancer. Frontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.817672
|
| 11 |
Nkafu Bechem Ndemazie, Andriana Inkoom, Dexter Ebesoh, Raviteja Bulusu, Esther Frimpong, Jose Trevino, Bo Han, Xue Zhu, Edward Agyare. Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10449-y
|
| 12 |
Khan Mohammad Imran, Rebecca M. Brock, Natalie Beitel-White, Manali Powar, Katie Orr, Kenneth N. Aycock, Nastaran Alinezhadbalalami, Zaid S. Salameh, Paige Eversole, Benjamin Tintera, Justin Markov Madanick, Alissa Hendricks-Wenger, Sheryl Coutermarsh-Ott, Rafael V. Davalos, Irving C. Allen. Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1352821
|
| 13 |
Shadab Md, Nabil A. Alhakamy, Hibah M. Aldawsari, Javed Ahmad, Waleed S. Alharbi, Hani Z. Asfour. Resveratrol loaded self-nanoemulsifying drug delivery system (SNEDDS) for pancreatic cancer: Formulation design, optimization and in vitro evaluation. Journal of Drug Delivery Science and Technology 2021; 64: 102555 doi: 10.1016/j.jddst.2021.102555
|
| 14 |
Julie Leca, Sébastien Martinez, Sophie Lac, Jérémy Nigri, Véronique Secq, Marion Rubis, Christian Bressy, Arnauld Sergé, Marie-Noelle Lavaut, Nelson Dusetti, Céline Loncle, Julie Roques, Daniel Pietrasz, Corinne Bousquet, Stéphane Garcia, Samuel Granjeaud, Mehdi Ouaissi, Jean Baptiste Bachet, Christine Brun, Juan L. Iovanna, Pascale Zimmermann, Sophie Vasseur, Richard Tomasini. Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness. Journal of Clinical Investigation 2016; 126(11): 4140 doi: 10.1172/JCI87734
|
| 15 |
Qingke Duan, Hehe Li, Chenggang Gao, Hengqiang Zhao, Shihong Wu, Heshui Wu, Chunyou Wang, Qiang Shen, Tao Yin. High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1209-9
|
| 16 |
Iera Hernandez-Unzueta, Aitor Benedicto, Irene Romayor, Alba Herrero, Eduardo Sanz, Beatriz Arteta, Elvira Olaso, Joana Márquez. Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance. Pancreas 2019; 48(4): 555 doi: 10.1097/MPA.0000000000001277
|
| 17 |
Rebecca A. Richmond, Quan V. Vuong, Christopher J. Scarlett. Cytotoxic Effect of Bitter Melon (Momordica charantia L.) Ethanol Extract and Its Fractions on Pancreatic Cancer Cells in vitro. Exploratory Research and Hypothesis in Medicine 2017; 2(4): 1 doi: 10.14218/ERHM.2017.00032
|
| 18 |
Nabil A. Alhakamy, Osama A. A. Ahmed, Usama A. Fahmy, Shadab Md. Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer. Pharmaceuticals 2021; 14(8): 729 doi: 10.3390/ph14080729
|
| 19 |
Sonam Kumari, Mohammed Sikander, Shabnam Malik, Manish K. Tripathi, Bilal B. Hafeez, Murali M. Yallapu, Subhash C. Chauhan, Sheema Khan, Meena Jaggi. Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells. Biomedicines 2021; 9(12): 1814 doi: 10.3390/biomedicines9121814
|
| 20 |
Zheng Zhou, Yaokun Dong, Na Li, Mengyue Niu, Shisheng Wang, Yuanzhang Zhou, Zhaolin Sun, Peng Chu, Zeyao Tang. An oleanolic acid derivative, K73‐03, inhibits pancreatic cancer cells proliferation in vitro and in vivo via blocking EGFR/Akt pathway. Cell Biology International 2022; 46(11): 1801 doi: 10.1002/cbin.11866
|
| 21 |
Jair Machado Espindola-Netto, Claudia C.S. Chini, Mariana Tarragó, Enfeng Wang, Shamit Dutta, Krishnendu Pal, Debabrata Mukhopadhyay, Mauro Sola-Penna, Eduardo N. Chini. Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer. Oncotarget 2017; 8(49): 85054 doi: 10.18632/oncotarget.18841
|
| 22 |
Iago Dillion Lima Cavalcanti, José Cleberson Santos Soares. Advances in Cancer Treatment. 2021; : 79 doi: 10.1007/978-3-030-68334-4_6
|
| 23 |
Clara Angeles, Danny Lascano, Gregory Veillette. Surgical Decision Making in Geriatrics. 2020; : 303 doi: 10.1007/978-3-030-47963-3_24
|
| 24 |
Asadur Rahman, Makoto Matsuyama, Akio Ebihara, Yuki Shibayama, Arif Ul Hasan, Hironori Nakagami, Fumiaki Suzuki, Jiao Sun, Tomoe Kobayashi, Hiroki Hayashi, Daisuke Nakano, Hideki Kobara, Tsutomu Masaki, Akira Nishiyama. Antiproliferative Effects of Monoclonal Antibodies against (Pro)Renin Receptor in Pancreatic Ductal Adenocarcinoma. Molecular Cancer Therapeutics 2020; 19(9): 1844 doi: 10.1158/1535-7163.MCT-19-0228
|
| 25 |
Takanori Adachi, Mitsuhiro Nakamura, Takahiro Iwai, Michio Yoshimura, Takashi Mizowaki. Delta-radiomics Approach Using Contrast-enhanced and Non-contrast-enhanced Computed Tomography Images for Predicting Distant Metastasis in Patients with Borderline Resectable Pancreatic Carcinoma. Advances in Radiation Oncology 2024; : 101669 doi: 10.1016/j.adro.2024.101669
|
| 26 |
Hui Zhang, Xuan Zhang, Xun Li, Wen‐Bo Meng, Zhong‐Tian Bai, Shao‐Zhen Rui, Zheng‐Feng Wang, Wen‐Ce Zhou, Xiao‐Da Jin. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. Journal of Cellular Physiology 2019; 234(1): 619 doi: 10.1002/jcp.26816
|
| 27 |
Jie Wu, Zhifang Li, Yong Li, Alex Pettitt, Feifan Zhou. Photothermal Effects of Reduced Graphene Oxide on Pancreatic Cancer. Technology in Cancer Research & Treatment 2018; 17 doi: 10.1177/1533034618768637
|
| 28 |
Felipe Camelo, Anne Le. The Heterogeneity of Cancer Metabolism. Advances in Experimental Medicine and Biology 2021; 1311: 77 doi: 10.1007/978-3-030-65768-0_5
|
| 29 |
Diana Behrens, Wolfgang Walther, Iduna Fichtner. Pancreatic cancer models for translational research. Pharmacology & Therapeutics 2017; 173: 146 doi: 10.1016/j.pharmthera.2017.02.013
|
| 30 |
Bo Tang, Yang Li, Guangying Qi, Shengguang Yuan, Zhenran Wang, Shuiping Yu, Bo Li, Songqing He. Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer. Scientific Reports 2015; 5(1) doi: 10.1038/srep13563
|
| 31 |
Sun Hwa Kim, Young Sik Woo, Kwang Hyuck Lee, Jong Kyun Lee, Kyu Taek Lee, Joo Kyung Park, Soo Hoon Kang, Ji Won Kim, Jae Keun Park, Sung-Wook Park. Preoperative EUS-guided FNA: effects on peritoneal recurrence and survival in patients with pancreatic cancer. Gastrointestinal Endoscopy 2018; 88(6): 926 doi: 10.1016/j.gie.2018.06.024
|
| 32 |
Seong Joon Park, Seung-Mi Kim, Jai-Hee Moon, Jeong Hee Kim, Jae-Sik Shin, Seung-Woo Hong, Yu Jin Shin, Dae-Hee Lee, Eun Young Lee, Ih-Yeon Hwang, Jeong Eun Kim, Kyu-pyo Kim, Yong Sang Hong, Won–Keun Lee, Eun Kyung Choi, Jung Shin Lee, Dong-Hoon Jin, Tae Won Kim. SAHA, an HDAC inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin. Tumor Biology 2016; 37(4): 4323 doi: 10.1007/s13277-015-4216-2
|
| 33 |
Haiqun Xing, Zhixin Hao, Wenjia Zhu, Dehui Sun, Jie Ding, Hui Zhang, Yu Liu, Li Huo. Preoperative prediction of pathological grade in pancreatic ductal adenocarcinoma based on 18F-FDG PET/CT radiomics. EJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00760-3
|
| 34 |
Xue Li, Mingming Zhen, Meilan Yu, Chen Zhou, Lei Li, Chunying Shu, Chunru Wang, Chunli Bai. Gadofullerene nanoparticles extend survival rate and down-regulate thrombin expression in orthotopic pancreatic cancer. Science China Materials 2022; 65(2): 508 doi: 10.1007/s40843-021-1761-3
|
| 35 |
Christy Goldsmith, Patricia Price, Timothy Cross, Sheila Loughlin, Ian Cowley, Nicholas Plowman. Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose Constraints. Seminars in Radiation Oncology 2016; 26(2): 149 doi: 10.1016/j.semradonc.2015.12.002
|
| 36 |
Sayan D. Gupta, Pappu S. Swapanthi, Deshetti Bhagya, Fernando Federicci, Gisela I. Mazaira, Mario D. Galigniana, Chavali V.S. Subrahmanyam, Naryanasamy L. Gowrishankar, Nulgumnalli M. Raghavendra. Rational Identification of Hsp90 Inhibitors as Anticancer Lead Molecules by Structure Based Drug Designing Approach. Anti-Cancer Agents in Medicinal Chemistry 2020; 20(3): 369 doi: 10.2174/1871520619666191111152050
|
| 37 |
Sarojamma Vemula, Manoj K. Gupta, Venkat R. Arva Tatireddygari, Ramakrishna Vadde. Theranostic Approach for Pancreatic Cancer. 2019; : 245 doi: 10.1016/B978-0-12-819457-7.00012-8
|
| 38 |
Jun Wan, Jie Cui, Lei Wang, Kunpeng Wu, Xiaoping Hong, Yulin Zou, Shuang Zhao, Hong Ke. RETRACTED ARTICLE: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathways. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0665-1
|
| 39 |
Kenya Kamimura, Takeshi Yokoo, Shuji Terai. Gene Therapy for Pancreatic Diseases: Current Status. International Journal of Molecular Sciences 2018; 19(11): 3415 doi: 10.3390/ijms19113415
|
| 40 |
Julia Rudno-Rudzińska, Wojciech Kielan, Maciej Guziński, Maciej Płochocki, Agnieszka Antończyk, Julita Kulbacka. New therapeutic strategy: Personalization of pancreatic cancer treatment-irreversible electroporation (IRE), electrochemotherapy (ECT) and calcium electroporation (CaEP) – A pilot preclinical study. Surgical Oncology 2021; 38: 101634 doi: 10.1016/j.suronc.2021.101634
|
| 41 |
Monu Kumar Shukla, Arpana Parihar, Chandrabose Karthikeyan, Deepak Kumar, Raju Khan. Multifunctional GQDs for receptor targeting, drug delivery, and bioimaging in pancreatic cancer. Nanoscale 2023; 15(36): 14698 doi: 10.1039/D3NR03161F
|
| 42 |
Lihua He, Lizhi Niu, Nikolai N. Korpan, Sajio Sumida, Yueyong Xiao, Jiaping Li, Barlian Sutedja, Youyong Lu, Jiansheng Zuo, Jianguo Liu, Kecheng Xu. Clinical Practice Guidelines for Cryosurgery of Pancreatic Cancer. Pancreas 2017; 46(8): 967 doi: 10.1097/MPA.0000000000000878
|
| 43 |
Sunil R. Hingorani, Lei Zheng, Andrea J. Bullock, Tara E. Seery, William P. Harris, Darren S. Sigal, Fadi Braiteh, Paul S. Ritch, Mark M. Zalupski, Nathan Bahary, Paul E. Oberstein, Andrea Wang-Gillam, Wilson Wu, Dimitrios Chondros, Ping Jiang, Sihem Khelifa, Jie Pu, Carrie Aldrich, Andrew E. Hendifar. HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma. Journal of Clinical Oncology 2018; 36(4): 359 doi: 10.1200/JCO.2017.74.9564
|
| 44 |
Athina Kladi-Skandali, Kleita Michaelidou, Andreas Scorilas, Konstantinos Mavridis. Long Noncoding RNAs in Digestive System Malignancies: A Novel Class of Cancer Biomarkers and Therapeutic Targets?. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/319861
|
| 45 |
Jin-Hui Zhu, Qiu-Liang Yan, Jian-Wei Wang, Yan Chen, Qing-Huang Ye, Zhi-Jiang Wang, Tao Huang. The Key Genes for Perineural Invasion in Pancreatic Ductal Adenocarcinoma Identified With Monte-Carlo Feature Selection Method. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.554502
|
| 46 |
Qun Chen, Wu-Jun Wang, Yun-Xuan Jia, Hao Yuan, Peng-Fei Wu, Wan-Li Ge, Ling-Dong Meng, Xu-Min Huang, Peng Shen, Tao-Yue Yang, Yi Miao, Jing-Jing Zhang, Kui-Rong Jiang. Effect of the transcription factor YY1 on the development of pancreatic endocrine and exocrine tumors: a narrative review. Cell & Bioscience 2021; 11(1) doi: 10.1186/s13578-021-00602-8
|
| 47 |
Andrea Marie Ibrahim, Yao-He Wang. Viro-immune therapy: A new strategy for treatment of pancreatic cancer. World Journal of Gastroenterology 2016; 22(2): 748-763 doi: 10.3748/wjg.v22.i2.748
|
| 48 |
Anbin Wang, Haisu Dai, Yi Gong, Chengcheng Zhang, Junjie Shu, Yuandeng Luo, Yan Jiang, Wei Liu, Ping Bie. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1340-7
|
| 49 |
Yi Yu, Jia-Tian Dong, Bing He, Yu-Feng Zou, Xue-Song Li, Chen-Hui Xi, Yuan Yu. LncRNA SNHG16 Induces the SREBP2 to Promote Lipogenesis and Enhance the Progression of Pancreatic Cancer. Future Oncology 2019; 15(33): 3831 doi: 10.2217/fon-2019-0321
|
| 50 |
Dehong Hu, Zhuwen Chen, Zonghai Sheng, Duyang Gao, Fei Yan, Teng Ma, Hairong Zheng, Mei Hong. A catalase-loaded hierarchical zeolite as an implantable nanocapsule for ultrasound-guided oxygen self-sufficient photodynamic therapy against pancreatic cancer. Nanoscale 2018; 10(36): 17283 doi: 10.1039/C8NR05548C
|
| 51 |
Carlotta Spano, Giulia Grisendi, Giulia Golinelli, Filippo Rossignoli, Malvina Prapa, Marco Bestagno, Olivia Candini, Tiziana Petrachi, Alessandra Recchia, Francesca Miselli, Giulia Rovesti, Giulia Orsi, Antonino Maiorana, Paola Manni, Elena Veronesi, Maria Serena Piccinno, Alba Murgia, Massimo Pinelli, Edwin M. Horwitz, Stefano Cascinu, Pierfranco Conte, Massimo Dominici. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-37433-6
|
| 52 |
Anthony Filson, Robert C. G. Martin. Infection reporting in patients undergoing irreversible electroporation of locally advanced pancreatic cancer. Journal of Surgical Oncology 2023; 128(4): 531 doi: 10.1002/jso.27310
|
| 53 |
Agnieszka Gajewska-Naryniecka, Urszula Szwedowicz, Zofia Łapińska, Julia Rudno-Rudzińska, Wojciech Kielan, Julita Kulbacka. Irreversible Electroporation in Pancreatic Cancer—An Evolving Experimental and Clinical Method. International Journal of Molecular Sciences 2023; 24(5): 4381 doi: 10.3390/ijms24054381
|
| 54 |
Paulina Bereza‐Carlson, Johan Nilsson, Bodil Andersson. Preoperative Risk Score for Early Mortality After Up‐Front Pancreatic Cancer Surgery: A Nationwide Cohort Study. World Journal of Surgery 2022; 46(11): 2769 doi: 10.1007/s00268-022-06678-8
|
| 55 |
Ryan Clay, Shadab A. Siddiqi. Theranostic Approach for Pancreatic Cancer. 2019; : 325 doi: 10.1016/B978-0-12-819457-7.00016-5
|
| 56 |
Patricia Coutinho de Souza, Ashish Ranjan, Rheal A Towner. Nanoformulations for Therapy of Pancreatic and Liver Cancers. Nanomedicine 2015; 10(9): 1515 doi: 10.2217/nnm.14.231
|
| 57 |
Yifan Duan, Xiaoyu Yin, Xiaorong Lai, Chao Liu, Wenjing Nie, Dongfeng Li, Zijun Xie, Zijun Li, Fan Meng. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033819895494
|
| 58 |
Neha Parveen, Afsana Sheikh, Mohammed A.S. Abourehab, Ritu Karwasra, Surender Singh, Prashant Kesharwani. Self-nanoemulsifying drug delivery system for pancreatic cancer. European Polymer Journal 2023; 190: 111993 doi: 10.1016/j.eurpolymj.2023.111993
|
| 59 |
Min‑Gu Lee, Kyu‑Shik Lee, Kyung‑Soo Nam. The association of changes in RAD51 and survivin expression levels with the proton beam sensitivity of Capan‑1 and Panc‑1 human pancreatic cancer cells. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4642
|
| 60 |
YUKARI NISHII, MIKI YAMAGUCHI, YASUTOSHI KIMURA, TADASHI HASEGAWA, HIROYUKI ABURATANI, HIROAKI UCHIDA, KOICHI HIRATA, YUJI SAKUMA. A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells. International Journal of Oncology 2015; 46(4): 1781 doi: 10.3892/ijo.2015.2880
|
| 61 |
Frank Zimmermann, Alexandros Papachristofilou, Viviane Hess, Christoph Kettelhack. Nur in seltenen Fällen besteht die Chance auf Heilung. Info Onkologie 2015; 18(5): 45 doi: 10.1007/s15004-015-0712-1
|
| 62 |
Xiao-Mei Luo, Li-Zhi Niu, Ji-Bing Chen, Ke-Cheng Xu. Advances in cryoablation for pancreatic cancer. World Journal of Gastroenterology 2016; 22(2): 790-800 doi: 10.3748/wjg.v22.i2.790
|
| 63 |
Giulia Fontana, Marco Riboldi, Chiara Gianoli, Cezarina I. Chirvase, Gaetano Villa, Chiara Paganelli, Paul E. Summers, Barbara Tagaste, Andrea Pella, Piero Fossati, Mario Ciocca, Guido Baroni, Francesca Valvo, Roberto Orecchia. MRI quantification of pancreas motion as a function of patient setup for particle therapy —a preliminary study. Journal of Applied Clinical Medical Physics 2016; 17(5): 60 doi: 10.1120/jacmp.v17i5.6236
|
| 64 |
Fundamentals of Cancer Detection, Treatment, and Prevention. 2022; : 341 doi: 10.1002/9783527838561.ch15
|
| 65 |
|
| 66 |
Jia-Rong Li, Ling Liu, Hui Luo, Ze-Guo Chen, Jian-Hua Wang, Nian-Feng Li. Long Noncoding RNA DUXAP8 Promotes Pancreatic Carcinoma Cell Migration and Invasion Via Pathway by miR-448/WTAP/Fak Signaling Axis. Pancreas 2021; 50(3): 317 doi: 10.1097/MPA.0000000000001751
|
| 67 |
Madeline T. Olson, Quan P. Ly, Aaron M. Mohs. Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation. Molecular Imaging and Biology 2019; 21(2): 200 doi: 10.1007/s11307-018-1239-2
|
| 68 |
Ryo Ashida, Mitsuhiro Nakamura, Michio Yoshimura, Takashi Mizowaki. Impact of interfractional anatomical variation and setup correction methods on interfractional dose variation in IMPT and VMAT plans for pancreatic cancer patients: A planning study. Journal of Applied Clinical Medical Physics 2020; 21(7): 49 doi: 10.1002/acm2.12883
|
| 69 |
Giorgia Mandili, Claudia Curcio, Sara Bulfamante, Laura Follia, Giulio Ferrero, Emanuela Mazza, Moitza Principe, Francesca Cordero, Maria Antonietta Satolli, Rosella Spadi, Andrea Evangelista, Daniele Giordano, Duy Viet, Paola Cappello, Francesco Novelli. In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination. Journal for ImmunoTherapy of Cancer 2020; 8(2): e001071 doi: 10.1136/jitc-2020-001071
|
| 70 |
E. A. Bykova, N. A. Falaleeva, L. Yu. Grivtsova. PANCREATIC CANCER, CURRENT THERAPEUTIC APPROACHES AND POSSIBLE PROSPECTS. Russian Journal of Biotherapy 2020; 19(4): 18 doi: 10.17650/1726-9784-2020-19-4-18-28
|
| 71 |
Lusine Demirkhanyan, Christopher S. Gondi. Clinical Applications of Non-Coding RNAs in Cancer. 2022; : 1 doi: 10.1016/B978-0-12-824550-7.00011-4
|
| 72 |
Yun-Fei Liu, Dong Luo, Xia Li, Zhi-Qiang Li, Xiao Yu, Hong-Wei Zhu. PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer. Pancreas 2021; 50(2): 227 doi: 10.1097/MPA.0000000000001747
|
| 73 |
Erwin Tomasich, Jakob Mühlbacher, Katharina Wöran, Teresa Hatziioannou, Merima Herac, Markus Kleinberger, Julia Maria Berger, Lea Katharina Dibon, Luzia Berchtold, Gerwin Heller, Elisabeth Sophie Bergen, Andrea Macher-Beer, Gerald Prager, Martin Schindl, Matthias Preusser, Anna Sophie Berghoff. Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma. Translational Research 2024; 271: 40 doi: 10.1016/j.trsl.2024.05.005
|
| 74 |
Manu Gnanamony, Christopher S. Gondi. Chemoresistance in pancreatic cancer: Emerging concepts. Oncology Letters 2017; 13(4): 2507 doi: 10.3892/ol.2017.5777
|
| 75 |
|
| 76 |
Tao Wang, Radhika Narayanaswamy, Huilan Ren, James W. Gillespie, Valery A. Petrenko, Vladimir P. Torchilin. Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer. Journal of Drug Targeting 2018; 26(5-6): 505 doi: 10.1080/1061186X.2017.1405424
|
| 77 |
Qing-Guo Liu, Yan-Ju Li, Lan Yao. Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK/AKT axis. Pancreatology 2018; 18(6): 678 doi: 10.1016/j.pan.2018.07.003
|
| 78 |
Deepanshi Dhar, Komal Raina, Dileep Kumar, Michael F. Wempe, Stacey M. Bagby, Todd M. Pitts, David J. Orlicky, Chapla Agarwal, Wells A. Messersmith, Rajesh Agarwal. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient‐derived xenograft tumors. Molecular Carcinogenesis 2020; 59(10): 1227 doi: 10.1002/mc.23251
|
| 79 |
Xingxing Li, Jingyun Li, Bin Zhang, Yuqing Gu, Qian Li, Guangliang Gu, Jiageng Xiong, Yanan Li, Xiaojun Yang, Zhuyin Qian. Comparative peptidome profiling reveals critical roles for peptides in the pathology of pancreatic cancer. The International Journal of Biochemistry & Cell Biology 2020; 120: 105687 doi: 10.1016/j.biocel.2020.105687
|
| 80 |
Jasmeet Dhaliwal. Exploring the Therapeutic Opportunities of the Tumour Microenvironment in Treating Pancreatic Ductal Adenocarcinoma: A Literature Review. Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal 2022; 6(11): 1 doi: 10.26685/urncst.406
|
| 81 |
Claudia C.S. Chini, Jair M. Espindola-Netto, Gourish Mondal, Anatilde M. Gonzalez Guerrico, Veronica Nin, Carlos Escande, Mauro Sola-Penna, Jin-San Zhang, Daniel D. Billadeau, Eduardo N. Chini. SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway. Clinical Cancer Research 2016; 22(10): 2496 doi: 10.1158/1078-0432.CCR-15-1760
|
| 82 |
Qinlei Liu, Jiayi Lan, Sandra Martínez-Jarquín, Wenjie Ge, Renato Zenobi. Screening Metabolic Biomarkers in KRAS Mutated Mouse Acinar and Human Pancreatic Cancer Cells via Single-Cell Mass Spectrometry. Analytical Chemistry 2024; 96(12): 4918 doi: 10.1021/acs.analchem.3c05741
|
| 83 |
Julia Benzel, Volker Fendrich. Familial Pancreatic Cancer. Oncology Research and Treatment 2018; 41(10): 611 doi: 10.1159/000493473
|
| 84 |
Suresh Chava, Meher B. Gayatri, Aramati B.M. Reddy. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019; : 25 doi: 10.1016/B978-0-12-817661-0.00003-2
|
| 85 |
Shuangshuang Lu, Tasqeen Ahmed, Pan Du, Yaohe Wang. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. International Journal of Molecular Sciences 2017; 18(6): 1201 doi: 10.3390/ijms18061201
|
| 86 |
Min Li, Huilan Xu. Fear stress enhanced xenograft pancreatic tumor growth through activating epithelial-mesenchymal transition. Pancreatology 2019; 19(2): 377 doi: 10.1016/j.pan.2019.01.002
|
| 87 |
Song Wang, Cecilie L. Bager, Morten A. Karsdal, Dimitrios Chondros, Darin Taverna, Nicholas Willumsen. Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02701-z
|
| 88 |
Konrad Klinghammer, Wolfgang Walther, Jens Hoffmann. Choosing wisely – Preclinical test models in the era of precision medicine. Cancer Treatment Reviews 2017; 55: 36 doi: 10.1016/j.ctrv.2017.02.009
|
| 89 |
Satoshi Uchida, Hiroaki Kinoh, Takehiko Ishii, Akitsugu Matsui, Theofilus Agrios Tockary, Kaori Machitani Takeda, Hirokuni Uchida, Kensuke Osada, Keiji Itaka, Kazunori Kataoka. Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety. Biomaterials 2016; 82: 221 doi: 10.1016/j.biomaterials.2015.12.031
|
| 90 |
Pan Pan, Chad Skaer, Jianhua Yu, Hui Zhao, He Ren, Kiyoko Oshima, Li-Shu Wang. Berries and other natural products in pancreatic cancer chemoprevention in human clinical trials. Journal of Berry Research 2017; 7(3): 147 doi: 10.3233/JBR-170159
|
| 91 |
Yongping Zhou, Ting Shan, Wenzhou Ding, Zhiyuan Hua, Yijun Shen, Zhihua Lu, Bo Chen, Tu Dai. Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo‐YAP signaling. Journal of Cellular Physiology 2018; 233(8): 5805 doi: 10.1002/jcp.26357
|
| 92 |
Felipe Camelo, Anne Le. The Heterogeneity of Cancer Metabolism. Advances in Experimental Medicine and Biology 2018; 1063: 73 doi: 10.1007/978-3-319-77736-8_5
|
| 93 |
Wan-Chi Tsai, Li-Yuan Bai, Yi-Jin Chen, Po-Chen Chu, Ya-Wen Hsu, Aaron M. Sargeant, Jing-Ru Weng. OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling. Oncotarget 2017; 8(17): 29233 doi: 10.18632/oncotarget.16450
|
| 94 |
Yuhei Kikkawa, Hideaki Ueda, Yusuke Uchinami, Norio Katoh, Hidefumi Aoyama, Yoichi M Ito, Kohei Yokokawa, Ye Chen, Taeko Matsuura, Naoki Miyamoto, Seishin Takao. Investigation of interfractional range variation owing to anatomical changes with beam directions based on water equivalent thickness in proton therapy for pancreatic cancer. Journal of Radiation Research 2024; doi: 10.1093/jrr/rrae069
|